PLK1 and non-small cell lung carcinoma: Interestingly, consistent with our results, in NSCLC, active PLK1 has been shown to upregulate the levels of p-Smad2, a TGF-β effector, leading to the promote metastasis and invasion thorough upregulates TNFAIP662.